- Home
- PWOD vs DMAC Comparison
PWOD vs DMAC Comparison
Compare PWOD & DMAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PWOD
- DMAC
- Stock Information
- Founded
- PWOD 1934
- DMAC 2000
- Country
- PWOD United States
- DMAC United States
- Employees
- PWOD N/A
- DMAC N/A
- Industry
- PWOD Major Banks
- DMAC Biotechnology: Pharmaceutical Preparations
- Sector
- PWOD Finance
- DMAC Health Care
- Exchange
- PWOD Nasdaq
- DMAC Nasdaq
- Market Cap
- PWOD 234.1M
- DMAC 267.7M
- IPO Year
- PWOD N/A
- DMAC N/A
- Fundamental
- Price
- PWOD $29.65
- DMAC $6.51
- Analyst Decision
- PWOD
- DMAC Strong Buy
- Analyst Count
- PWOD 0
- DMAC 3
- Target Price
- PWOD N/A
- DMAC $7.00
- AVG Volume (30 Days)
- PWOD 11.6K
- DMAC 80.9K
- Earning Date
- PWOD 01-29-2025
- DMAC 03-18-2025
- Dividend Yield
- PWOD 4.20%
- DMAC N/A
- EPS Growth
- PWOD 0.64
- DMAC N/A
- EPS
- PWOD 2.35
- DMAC N/A
- Revenue
- PWOD $68,377,000.00
- DMAC N/A
- Revenue This Year
- PWOD N/A
- DMAC N/A
- Revenue Next Year
- PWOD N/A
- DMAC N/A
- P/E Ratio
- PWOD $12.97
- DMAC N/A
- Revenue Growth
- PWOD 6.11
- DMAC N/A
- 52 Week Low
- PWOD $17.01
- DMAC $2.14
- 52 Week High
- PWOD $34.56
- DMAC $6.82
- Technical
- Relative Strength Index (RSI)
- PWOD 38.00
- DMAC 62.22
- Support Level
- PWOD $31.04
- DMAC $5.75
- Resistance Level
- PWOD $31.56
- DMAC $6.82
- Average True Range (ATR)
- PWOD 0.53
- DMAC 0.30
- MACD
- PWOD -0.14
- DMAC 0.02
- Stochastic Oscillator
- PWOD 0.00
- DMAC 74.48
About PWOD Penns Woods Bancorp Inc.
Penns Woods Bancorp Inc is the bank holding company for Jersey Shore State Bank and Luzerne Bank. The banks serve customers in North Central and North Eastern Pennsylvania through their retail banking, commercial banking, mortgage services and financial services divisions. The Banks are engaged in commercial and retail banking which includes the acceptance of time, savings, and demand deposits, the funding of commercial, consumer, and mortgage loans, and safe deposit services. Utilizing a branch office network, ATMs, Internet, and telephone banking delivery channels, the Banks deliver their products and services to the communities residing in.
About DMAC DiaMedica Therapeutics Inc.
DiaMedica Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is principally engaged in the business activity of developing treatments for unmet clinical needs or where no therapies are available with a primary focus on chronic kidney disease and acute ischemicstroke. Its pipeline product DM199 is a recombinant form of human tissue kallikrein-1.